| 1 |
31215459 | Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models. | 2019 Jun 18 |
2 |
| 2 |
21338601 | Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo. | 2011 May 1 |
1 |
| 3 |
18628478 | Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo. | 2008 Jul 15 |
2 |
| 4 |
19020730 | TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells. | 2008 Dec |
3 |
| 5 |
17431114 | Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. | 2007 Apr |
6 |